4.0
14. Sept. 2024
Aktueller Mitarbeiter, mehr als 8 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Work with smart, committed research and development experts. Great collaborations. Help create life-saving medicines.
Kontras
New focus on quarterly earnings calls vs. long-term thinking and game-changing science. Recent influx of non-experts from "big-3" consultanting company alumni prioritizing hype over substance.